Search

Jeffrey S. Parkin

Examiner (ID: 2776)

Most Active Art Unit
1648
Art Unit(s)
1648, 1641, 1813, 1671
Total Applications
1731
Issued Applications
935
Pending Applications
260
Abandoned Applications
571

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6234916 [patent_doc_number] => 20100266620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Immunoconjugates for treatment of infectious diseases' [patent_app_type] => utility [patent_app_number] => 11/655266 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8030 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266620.pdf [firstpage_image] =>[orig_patent_app_number] => 11655266 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/655266
Immunoconjugates for treatment of infectious diseases Jan 18, 2007 Abandoned
Array ( [id] => 6275106 [patent_doc_number] => 20100256040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 11/625200 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 44586 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256040.pdf [firstpage_image] =>[orig_patent_app_number] => 11625200 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/625200
COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION Jan 18, 2007 Abandoned
Array ( [id] => 5259646 [patent_doc_number] => 20070213278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Arrays with cleavable linkers' [patent_app_type] => utility [patent_app_number] => 11/645273 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 33089 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213278.pdf [firstpage_image] =>[orig_patent_app_number] => 11645273 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/645273
Arrays with cleavable linkers Dec 21, 2006 Abandoned
Array ( [id] => 5135999 [patent_doc_number] => 20070077628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases' [patent_app_type] => utility [patent_app_number] => 10/568707 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24911 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077628.pdf [firstpage_image] =>[orig_patent_app_number] => 10568707 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/568707
Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases Dec 13, 2006 Abandoned
Array ( [id] => 6392321 [patent_doc_number] => 20100303848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'VACCINATION METHOD' [patent_app_type] => utility [patent_app_number] => 12/086350 [patent_app_country] => US [patent_app_date] => 2006-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 2132 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303848.pdf [firstpage_image] =>[orig_patent_app_number] => 12086350 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/086350
VACCINATION METHOD Dec 12, 2006 Abandoned
Array ( [id] => 4764625 [patent_doc_number] => 20080175836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Immunogenic composition based on conditionally live virion and method for producing the same' [patent_app_type] => utility [patent_app_number] => 11/634508 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22357 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175836.pdf [firstpage_image] =>[orig_patent_app_number] => 11634508 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/634508
Immunogenic composition based on conditionally live virion and method for producing the same Dec 5, 2006 Abandoned
Array ( [id] => 7689479 [patent_doc_number] => 20070105219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Retrovirus from the HIV group and its use' [patent_app_type] => utility [patent_app_number] => 11/634254 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11679 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105219.pdf [firstpage_image] =>[orig_patent_app_number] => 11634254 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/634254
Retrovirus from the HIV group and its use Dec 5, 2006 Abandoned
Array ( [id] => 5045954 [patent_doc_number] => 20070264627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Retrovirus from the HIV group and its use' [patent_app_type] => utility [patent_app_number] => 11/634155 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11676 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264627.pdf [firstpage_image] =>[orig_patent_app_number] => 11634155 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/634155
Retrovirus from the HIV group and its use Dec 5, 2006 Abandoned
Array ( [id] => 6392413 [patent_doc_number] => 20100303858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Chimeric HIV-1 Glycoproteins and Their Biological Applications' [patent_app_type] => utility [patent_app_number] => 12/085632 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 9153 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303858.pdf [firstpage_image] =>[orig_patent_app_number] => 12085632 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/085632
Chimeric HIV-1 Glycoproteins and Their Biological Applications Nov 27, 2006 Abandoned
Array ( [id] => 4988578 [patent_doc_number] => 20070154917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Compositions and method for treating viral infections' [patent_app_type] => utility [patent_app_number] => 11/605017 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25952 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154917.pdf [firstpage_image] =>[orig_patent_app_number] => 11605017 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/605017
Adjuvant comprising non-toxic cross-linked muramyl dipeptide (MDP) microparticles derived from Propionibacterium acnes Nov 27, 2006 Issued
Array ( [id] => 5374629 [patent_doc_number] => 20090312190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses' [patent_app_type] => utility [patent_app_number] => 12/094503 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18030 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312190.pdf [firstpage_image] =>[orig_patent_app_number] => 12094503 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/094503
Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses Nov 20, 2006 Abandoned
Array ( [id] => 5539136 [patent_doc_number] => 20090220941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'COMPOSITIONS FOR- DETECTING OF INFLUENZA VIRUSES AND KITS AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 12/091665 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14228 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220941.pdf [firstpage_image] =>[orig_patent_app_number] => 12091665 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/091665
COMPOSITIONS FOR- DETECTING OF INFLUENZA VIRUSES AND KITS AND METHODS USING SAME Oct 24, 2006 Abandoned
Array ( [id] => 6054617 [patent_doc_number] => 20110110977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Multiclade HIV Vaccines' [patent_app_type] => utility [patent_app_number] => 12/083905 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21115 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110977.pdf [firstpage_image] =>[orig_patent_app_number] => 12083905 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/083905
Multiclade HIV Vaccines Oct 16, 2006 Abandoned
Array ( [id] => 7502327 [patent_doc_number] => 08034355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase' [patent_app_type] => utility [patent_app_number] => 12/089353 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14392 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034355.pdf [firstpage_image] =>[orig_patent_app_number] => 12089353 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/089353
Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase Oct 5, 2006 Issued
Array ( [id] => 5193527 [patent_doc_number] => 20070082011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Recombinant proteins from filoviruses and their use' [patent_app_type] => utility [patent_app_number] => 11/545093 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19857 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082011.pdf [firstpage_image] =>[orig_patent_app_number] => 11545093 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/545093
Drosophila cell lines producing recombinant secretable filovirus surface glycoproteins lacking the membrane spanning domain Oct 4, 2006 Issued
Array ( [id] => 5204503 [patent_doc_number] => 20070025983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Compounds capable of inhibiting HIV-1 infection' [patent_app_type] => utility [patent_app_number] => 11/544346 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9115 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20070025983.pdf [firstpage_image] =>[orig_patent_app_number] => 11544346 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/544346
Compounds capable of inhibiting HIV-1 infection Oct 4, 2006 Issued
Array ( [id] => 5952341 [patent_doc_number] => 20110033446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Treatment of HIV-1-infected individuals to reduce risk of coronary artery disease and suppress virus replication' [patent_app_type] => utility [patent_app_number] => 11/528431 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12719 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033446.pdf [firstpage_image] =>[orig_patent_app_number] => 11528431 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/528431
Method of suppressing human immunodeficiency virus (HIV) replication in a subject by administering a liver X receptor (LXR) agonist Sep 27, 2006 Issued
Array ( [id] => 5004559 [patent_doc_number] => 20070202127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids' [patent_app_type] => utility [patent_app_number] => 11/529806 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 84 [patent_figures_cnt] => 84 [patent_no_of_words] => 37619 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202127.pdf [firstpage_image] =>[orig_patent_app_number] => 11529806 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/529806
Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids Sep 27, 2006 Abandoned
Array ( [id] => 5241788 [patent_doc_number] => 20070020280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Compositions and methods for inhibition of HIV-1 infection' [patent_app_type] => utility [patent_app_number] => 11/520556 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 21986 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020280.pdf [firstpage_image] =>[orig_patent_app_number] => 11520556 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/520556
Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors Sep 11, 2006 Issued
Array ( [id] => 5101763 [patent_doc_number] => 20070185025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Filoviral immunosuppressive peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/518641 [patent_app_country] => US [patent_app_date] => 2006-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 29001 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185025.pdf [firstpage_image] =>[orig_patent_app_number] => 11518641 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/518641
Filoviral immunosuppressive peptides and uses thereof Sep 10, 2006 Abandoned
Menu